Claim OwnershipHeart Failure
Subscribed: 4Played: 11
Subscribe
© 2025
Description
Approximately 6.7 million Americans over 20 years of age have heart failure. This podcast series is designed for healthcare professionals navigating the complexities of heart failure care. Each episode unpacks core themes—from the nuances of diagnosis and phenotypes to managing Cardiovascular-kidney-metabolic health. and obesity's role in HFpEF and HFmrEF.
Experts spotlight combination guideline-directed medical therapy, explore cutting-edge device interventions, and share real-world strategies for applying evidence-based practices across various patient populations. Listen now for insightful conversations that bridge the gap between guidelines and patient care, for practical application.
Experts spotlight combination guideline-directed medical therapy, explore cutting-edge device interventions, and share real-world strategies for applying evidence-based practices across various patient populations. Listen now for insightful conversations that bridge the gap between guidelines and patient care, for practical application.
4 Episodes
Reverse
This episode explores the foundational treatment pillars for HFmrEF and HFpEF, emphasizing the clinical rationale behind simultaneous or rapid-sequential initiation of combination guideline-directed medical therapy (GDMT). Experts also address real-world barriers to implementation—such as workflow, access, and coordination—and share practical strategies to accelerate therapy and improve outcomes.
Experts in this episode, explore tools for assessing ischemic stroke and bleeding risks, principles of anticoagulant dosing in atrial fibrillation, and alternative treatments for patients who can't take anticoagulants. This podcast discusses monitoring parameters, reversal agents, and best practices for perioperative anticoagulation management. Listen now for practical insights on optimizing patient care.
In this episode, experts unpack the emerging concept of cardio-kidney-metabolic (CKM) syndrome and its pivotal role in the development and progression of HFpEF and HFmrEF. Listeners will learn how to identify CKM disease states and comorbidities while addressing risk-stratification, interpret diagnostic markers beyond eGFR, and consider integration of evidence-based metabolic therapies (SGLT2 inhibitors, MRAs, GLP-1 receptor agonists) within a multidisciplinary care model.
Experts review definitions, diagnostic testing, risk prediction tools, and phenotypes of HFpEF. Listen to learn about common mimickers of HFpEF, and diagnostic clues and tests to help identify these diagnoses.
Comments
Download from Google Play
Download from App Store
United States